Procalcitonin increased
(UMLS:C1868796)
- UMLS ID:
- C1868796
- MeSH ID:
- N/A
Synonym(s)
1.
Procalcitonin increased
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Acetaminophen | FAERS: 25 | US FAERS | |
| 2 | Clozapine | FAERS: 9 | US FAERS | |
| 3 | Olanzapine | FAERS: 5 | US FAERS | |
| 4 | Etoposide | FAERS: 4 | US FAERS | |
| 5 | Deferasirox | FAERS: 2 | US FAERS | |
| 6 | Everolimus | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Glatiramer Acetate | FAERS: 2 | US FAERS | |
| 8 | Hydrochlorothiazide | FAERS: 2 | US FAERS | |
| 9 | Moxifloxacin | FAERS: 2 | US FAERS | |
| 10 | 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol | FAERS: 1 | US FAERS | |
| 11 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 12 | Atorvastatin | FAERS: 1 | US FAERS | |
| 13 | Bendamustine Hydrochloride | FAERS: 1 | US FAERS | |
| 14 | Capecitabine | FAERS: 1 | US FAERS | |
| 15 | Dasatinib | FAERS: 1 | US FAERS | |
| 16 | Epirubicin | FAERS: 1 | US FAERS | |
| 17 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 18 | Haloperidol | FAERS: 1 | US FAERS | |
| 19 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 20 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 21 | LCZ 696 | FAERS: 1 | US FAERS | |
| 22 | Lamotrigine | FAERS: 1 | US FAERS | |
| 23 | Linezolid | FAERS: 1 | US FAERS | |
| 24 | Mesalamine | FAERS: 1 | US FAERS | |
| 25 | Pamidronate | FAERS: 1 | US FAERS | |
| 26 | Risedronic Acid | FAERS: 1 | US FAERS | |
| 27 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 28 | Sunitinib | FAERS: 1 | US FAERS | |
| 29 | Tacrolimus | FAERS: 1 | US FAERS | |
| 30 | Teriparatide | FAERS: 1 | US FAERS | |
| 31 | Valproic Acid | FAERS: 1 | US FAERS | |
| 32 | contrast agent BR1 | FAERS: 1 | US FAERS | |
| 33 | hydrochlorothiazide-triamterene | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.